Medicine guide

ALYFTREK

As listed in the register: ALYFTREK

4 mg + 20 mg + 50 mg · tablet

Active substance: Vanzacaftor (Vanzacaftor Calcium) + Tezacaftor + Deutivacaftor
Used in: Breathing, airways, allergies and cough
Made by: Vertex Pharmaceuticals (Canada) Incorporated
Source: Official label

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBreathing, airways, allergies and coughR07AX

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Made by	Vertex Pharmaceuticals (Canada) Incorporated
Active substance	Vanzacaftor (Vanzacaftor Calcium) + Tezacaftor + Deutivacaftor
Used in	Breathing, airways, allergies and cough
Strength	4 mg + 20 mg + 50 mg
Form	tablet
Classification	R07AX · Breathing, airways, allergies and cough
Route	oral
Dispensing (as stated by the register)	PRESCRIPTION
Status	Marketed
Marketed	Yes, according to the register
DIN	02559676
DPD drug code	106280

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

These contain the same substance. That does not mean one can replace another — ask a pharmacist.